Glial mitogenic factors lacking an N-terminal signal sequence

Details Glial mitogenic factors lacking an N-terminal signal sequence Glial mitogenic factors lacking an N-terminal signal sequence

2008-01-15

2008-01-15

Chan, Christina (Department: 1649)

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Recombinant dna technique included in method of making a...

C435S320100, C435S325000, C536S023500

Reexamination Certificate

active

07319019

ABSTRACT:
Disclosed is the characterization and purification of DNA encoding a numerous polypeptides useful for the stimulation of glial cell (particularly, Schwann cell) mitogenesis and treating glial cell tumors. Also disclosed are DNA sequences encoding novel polypeptides which may have use in stimulating glial cell mitogenesis and treating glial cell tumors. Methods for the synthesis, purification and testing of both known and novel polypeptides for their use as both therapeutic and diagnostic aids in the treatment of diseases involving glial cells are also provided. Also included is the mature GGF peptide and the DNA encoding said peptide, exclusive of the N-terminal signal sequence. The mature GGF peptide and DNA encoding the same are also useful for treatment of conditions of the central nervous system. Methods are also provided for the use of these polypeptides for the preparation of antibody probes useful for both diagnostic and therapeutic use in diseases involving glial cells.

REFERENCES:
patent: 4935341 (1990-06-01), Barbmann et al.
patent: 4968603 (1990-11-01), Slamon et al.
patent: 5367060 (1994-11-01), Vandlen et al.
patent: WO8906692 (1989-07-01), None
patent: WO9014357 (1990-11-01), None
patent: WO9115230 (1991-10-01), None
patent: WO9118921 (1991-12-01), None
patent: WO9212174 (1992-07-01), None
patent: WO9322339 (1993-11-01), None
patent: WO9322424 (1993-11-01), None
Lemke et al.,Fed. Proceed., vol. 42, pp. 2627-2629, 1983.
Lemke et al,J. Neurosci., vol. 4, pp. 75-83, 1984.
Sennaro, ED.,Remington's Pharmaceutical Science, 18th ED., pp. 1300-1301, 1990.
Development Neuroscience, vol. 20, pp. 512-517, 1998.
J. Nrurobio., vol. 43, pp. 150-158, 2000 (Abstract Only).
Lemke et al., “Identification and Purification of Glial Growth Factor1”, J. Neuroscience, vol. 4, No. 1, pp. 75-83 (Jan. 1984).
Brockes, “Assay and Isolation of Glial Growth Factor from the Bovine Pituitary”, Methods in Enzymology, 147: 217-225 (1987).
Davis et al., “Platelet-derived Growth Factors and Fibroblasts Growth Factors Are Mitogens for Rat Schwann Cells”, J. Cell Biology 110: 1353 (Apr. 1990).
Peles et al., “Isolation of the Neu/HER-sStimulatory Ligand: A44 Ka Glyco-protein That Induces Differentiation of Mammary Tumor Cells”, Cell 69: 205 (Apr. 1992).
Lupu et al., “Direct Intera-tion of a Ligand for the eroB2 Oncogene Product with the EGF Receptor adnd p185erbB2”, Science 249: 1552 (Sep. 1990).
Yarden et al., “Biochemical Analysis of the Ligand for the neu Oncogenic Receptor”, Biochemistry 30: 3543 (1991).
Dobashi et al., “Characterization of a neu/c-erbB-2 protein-specific activating factor”, P.N.A.S., U.S.A. 88: 8582 (Oct. 1991).
Tarakhovsky et al., “A 25 kDa polypeptide in the ligand for p185neu and is secreted by activated macrophages”, Oncogene 6: 2187 (1991).
Davis et al., “Isolation and characterization of the neu protein-specific activating factor from human ATL-2 cell conditioned medium”, Biochem. Biophys. Research Communications 179: 1536 (Sep. 1991).
Huang et al., “Purification and Characterization of the neu/erb B2 Ligand-Growth Factor from Bovine Kidney”, J. Biol. Chem. 257: 11508 (Jun. 1992).
Lupu et al., “Characterization of a growth factor that binds exclusively to the erbB-2 receptor and induces cellular responses”, P.N.A.S., U.S.A. 89: 2287 (Mar. 1992).
Holmes et al., “Identification of Heregulin, a Specific Activator of p185erbB2”, Science 256: 1205 (May 1992).
Wen et al., “Heu Differentiation Factor: A Transmembrane Glycoprotein Containing an EGF Domain and an Immunoglobulin Homology Unit”, Cell 69: 559 (May 1992).
Yarden, “Growth Factor Receptor Tyrosine Kinases”, Ann. Rev. Biochem. 57: 443-478 (1988).
World Patents Index, week 7123, AN=71-400056S, Derwent Publications, Abstract, Teikoku Hormone Manuf. Ltd, 1992.
Benveniste, E.N. et al., P.N.A.S., “Purification and characterization of a human T-lymphocyte-derived glial growth promoting factor”, 82: 3930-3934, Jun. 1985.
Brookes et al., “Purification and Preliminary Characterization of a Glial Growth Factor from the Bovine Pituitary”, J. Biol. Chem. 255: 18, 8374-8377 (Sep. 1980).
Brookes et al., “The neuron as a source of mitogen: its influence on the proliferation of glial and non-neural cells”, Garrod and Feldman eds, pp. 309-327 (1980).
Lemke et al. “An Immunochemical Approach to the Purification and Characterization of Glial Growth Factor”, Monoclonal Antibodies to Neural Antigens, McKay, Raff and Reichardt, eds. pp. 133-140 (1981).

Affiliated with

Also associated with

Rating

Glial mitogenic factors lacking an N-terminal signal sequence does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glial mitogenic factors lacking an N-terminal signal sequence, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glial mitogenic factors lacking an N-terminal signal sequence will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2797577